These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2783691)

  • 1. Regions of the rat osteocalcin gene which mediate the effect of 1,25-dihydroxyvitamin D3 on gene transcription.
    Demay MB; Roth DA; Kronenberg HM
    J Biol Chem; 1989 Feb; 264(4):2279-82. PubMed ID: 2783691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3.
    Demay MB; Gerardi JM; DeLuca HF; Kronenberg HM
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):369-73. PubMed ID: 2153298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the rat osteocalcin gene: stimulation of promoter activity by 1,25-dihydroxyvitamin D3.
    Yoon KG; Rutledge SJ; Buenaga RF; Rodan GA
    Biochemistry; 1988 Nov; 27(23):8521-6. PubMed ID: 3265336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene.
    Nanes MS; Kuno H; Demay MB; Kurian M; Hendy GN; DeLuca HF; Titus L; Rubin J
    Endocrinology; 1994 Mar; 134(3):1113-20. PubMed ID: 8119149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of sequence elements in mouse calbindin-D28k gene that confer 1,25-dihydroxyvitamin D3- and butyrate-inducible responses.
    Gill RK; Christakos S
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2984-8. PubMed ID: 8464915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonhypercalcemic 1,25-(OH)2D3 analogs potently induce the human osteocalcin gene promoter stably transfected into rat osteosarcoma cells (ROSCO-2).
    Morrison NA; Eisman JA
    J Bone Miner Res; 1991 Aug; 6(8):893-9. PubMed ID: 1785378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo.
    Sims NA; White CP; Sunn KL; Thomas GP; Drummond ML; Morrison NA; Eisman JA; Gardiner EM
    Mol Endocrinol; 1997 Oct; 11(11):1695-708. PubMed ID: 9328351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vitamin D-responsive element in the rat bone Gla protein gene is an imperfect direct repeat that cooperates with other cis-elements in 1,25-dihydroxyvitamin D3- mediated transcriptional activation.
    Terpening CM; Haussler CA; Jurutka PW; Galligan MA; Komm BS; Haussler MR
    Mol Endocrinol; 1991 Mar; 5(3):373-85. PubMed ID: 1653893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human osteocalcin promoter directs bone-specific vitamin D-regulatable gene expression in transgenic mice.
    Kesterson RA; Stanley L; DeMayo F; Finegold M; Pike JW
    Mol Endocrinol; 1993 Mar; 7(3):462-7. PubMed ID: 8483481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
    Chen TL; Hauschka PV; Cabrales S; Feldman D
    Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts.
    Veenstra TD; Fahnestock M; Kumar R
    Biochemistry; 1998 Apr; 37(17):5988-94. PubMed ID: 9558335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the vitamin D3 analog 1 alpha, 25-dihydroxyvitamin D3-3 beta-bromoacetate on rat osteosarcoma cells: comparison with 1 alpha, 25-dihydroxyvitamin D3.
    Van Auken M; Buckley D; Ray R; Holick MF; Baran DT
    J Cell Biochem; 1996 Dec; 63(3):302-10. PubMed ID: 8913881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA sequences downstream from the vitamin D response element of the rat osteocalcin gene are required for ligand-dependent transactivation.
    Sneddon WB; Bogado CE; Kiernan MS; Demay MB
    Mol Endocrinol; 1997 Feb; 11(2):210-7. PubMed ID: 9013768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes.
    Clemens TL; Tang H; Maeda S; Kesterson RA; Demayo F; Pike JW; Gundberg CM
    J Bone Miner Res; 1997 Oct; 12(10):1570-6. PubMed ID: 9333117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of permanent cell lines exhibiting vitamin D-dependent expression of beta-galactosidase activity.
    Negishi Y; Kajiyama N; Kawashima K; Fujishima T; Takayama H; Endo H; Kawaguchi R
    Biochem Pharmacol; 1999 Aug; 58(3):465-70. PubMed ID: 10424766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Gla protein messenger ribonucleic acid is regulated by both 1,25-dihydroxyvitamin D3 and 3',5'-cyclic adenosine monophosphate in rat osteosarcoma cells.
    Theofan G; Price PA
    Mol Endocrinol; 1989 Jan; 3(1):36-43. PubMed ID: 2464756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of transcriptional inhibitors on the bone gamma-carboxyglutamic acid protein response to 1,25-dihydroxyvitamin D3 in osteosarcoma cells.
    Pan LC; Price PA
    J Biol Chem; 1984 May; 259(9):5844-7. PubMed ID: 6609159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.